Suchergebnisse - "rucaparib"

PubPharm (59)

1

Hematological Toxicities with PARP Inhibitors in Prostate Cancer : A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials

enthalten in: Cancers | 2023

von Bowling, G. | Swargaloganathan, P. | Heintz, C. | +4

2

Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer

enthalten in: Clinical genitourinary cancer | 2023

von Gamba, T. | Paparo, J. | Panepinto, O. | +3

3

Efficacy and Safety of PARP Inhibitor Therapy in Advanced Ovarian Cancer : A Systematic Review and Network Meta-analysis of Randomized Controlled Trials

enthalten in: Current computer-aided drug design | 2023

von Chen, J. | Wu, X. | Wang, H. | +3

4

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot : Development, Validation and Clinical Validation for Therapeutic Drug Monitoring

enthalten in: Pharmaceutics | 2023

von Canil, G. | Orleni, M. | Posocco, B. | +7

5

The effect of PARP inhibitors in homologous recombination proficient ovarian cancer : meta-analysis

enthalten in: Journal of chemotherapy (Florence, Italy) | 2023

von Skelin, M. | Šarčević, D. | Lešin Gaćina, D. | +3

6

Novel breakthroughs in advanced prostate cancer management

enthalten in: Expert review of anticancer therapy | 2023

von Lilly, E. | Sarkis, J. | Mahmoud, O. | +3

7

Hematological Toxicities with PARP Inhibitors in Prostate Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials

in: Cancers | 2023

von Gartrell C. Bowling | Piragash Swargaloganathan | Carly Heintz | +4

8

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring

in: Pharmaceutics | 2023

von Giovanni Canil | Marco Orleni | Bianca Posocco | +7

9

Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi) : Mechanisms and Potential to Reverse

enthalten in: Current oncology reports | 2022

von Washington, C. | Moore, K.

10

Comparative Analyses of Poly(ADP-Ribose) Polymerase Inhibitors

enthalten in: International journal of toxicology | 2022

von Guha, M. | Sobol, Z. | Martin, M. | +7

1
2
3
4
5
6
Nächster »
[6]